GSP Crop Science Q3 FY26 Concall Decoded: Patent Party Hits 20% Revenue Mix, China Dependency Still Crashes The Gate

1. Opening Hook

Just when agrochemical companies were preparing for another season of weather tantrums, fertilizer shortages, and crude price drama, ‎‏‎‏‎‏‎‏‎‏‎‏‎‏‎‏‎‏GSP Crop Science walked in claiming it can dodge El Nino, China dependency, and Middle East shipping chaos with patents and pricing power.

Management sounded like that overconfident topper who says the exam was “manageable” while everyone else is still crying outside the hall.

The company is betting heavily on patented combinations, premium margins, and a growing B2C network to keep growth alive. And honestly, the story gets more interesting once you realise they want patented products to become almost half the business in three years.

Bold claim. Bigger execution challenge.

Read on, because the agrochemical soap opera only gets better from here.

2. At a Glance

• Revenue up strongly – Nine-month revenue touched INR1,114 crore, and management acted like this was just warm-up practice.
• EBITDA up 32% – Premium products finally started paying rent.
• PAT up to INR75 crore – Exceptional items tried to spoil the party, but profits survived.
• Patented products at 20% of sales – Tiny three years ago, now behaving like the company’s favourite child.
• Gross margins improving – Patented products earn 20%-25% more margin than generic products. Not bad for glorified crop sprays.
• Export mix at 20% – Brazil is next on the wishlist because India clearly wasn’t enough.

3. Management’s Key Commentary

“We have already received 102 patents and 108 patents are in pipeline.”

(Translation: The patent cupboard is full, now management just needs to actually commercialize them before investors lose patience.) 😏

“Our patented product business from 3% before 3 years, now it is 17%.”

(Translation: Premium products are no longer side characters. They are slowly becoming the lead actor.)

“We have almost 5,000 distributors across India and 24 C&F locations.”

(Translation: GSP has built a decent rural distribution machine, because selling agrochemicals is useless if the farmer cannot find them.)

“This product has been a blockbuster product for us wherein we have scaled volumes to almost INR50 crore to INR70 crore.”

(Translation: PCT-410 turned out to be the IPL star player of the portfolio.)

“We have done revenue of INR1,114 crore and EBITDA of INR153 crore.”

(Translation: The business is growing well, and margins are finally looking less depressing.)

“We have increased our price from 10% to 15% already to the market.”

(Translation: Crude oil and logistics costs went crazy, so management politely handed the bill to customers.)

“In the upcoming 3 years, almost 40% to 50% revenue will be coming from these patented products.”

(Translation: Management wants GSP to transform from a generic agrochemical player into a premium-margin specialty business. Easy to say, harder to pull off.)

4. Numbers Decoded